Table 1.
All Subjects | Training Cohort | Testing Cohort | p-Value | |
---|---|---|---|---|
n | 41 | 30 | 11 | |
Age (years) | 57 ± 6 | 58 ± 7 | 56 ± 3 | 0.57 |
Sex | ||||
Female | 3 | 3 | 0 | 0.68 |
Male | 38 | 27 | 11 | |
Time Interval (days) | 32 ± 3 | 32 ± 3 | 33 ± 3 | 0.48 |
Lymph Node Reduction (%) | 66% [53–82%] | 77% [53–82%] | 62% [58–67%] | 0.34 |
Lymph Node Response | 0.19 | |||
Good Response (> 66%) | 20 | 17 | 3 | |
Poor Response (≤ 66%) | 21 | 13 | 8 | |
Overall Stage | 0.95 | |||
IVa | 39 | 28 | 11 | |
IVb | 2 | 2 | 0 | |
T Stage | 0.04 | |||
1 | 6 | 5 | 1 | |
2 | 15 | 7 | 8 | |
3 | 11 | 10 | 1 | |
4 | 9 | 8 | 1 | |
N Stage | 0.75 | |||
2a | 2 | 1 | 1 | |
2b | 20 | 14 | 6 | |
2c | 18 | 14 | 4 | |
3 | 1 | 1 | 0 |
Time interval is the number of days between the pretreatment scan and follow-up scan. Change in lymph node volume was assessed at this time. Lymph node reduction is the percent change in volume of the lymph node between the pretreatment and follow-up scan. Numerical data are mean ± standard deviation or median [interquartile range].